Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
D Sinha, N Sarkar, J Biswas, A Bishayee - Seminars in cancer biology, 2016 - Elsevier
Globally, breast cancer is the most frequently diagnosed cancer among women. The major
unresolved problems with metastatic breast cancer is recurrence after receiving objective …
unresolved problems with metastatic breast cancer is recurrence after receiving objective …
Resveratrol as an adjuvant for normal tissues protection and tumor sensitization
Cancer is one of the most complicated diseases in present-day medical science. Yearly,
several studies suggest various strategies for preventing carcinogenesis. Furthermore …
several studies suggest various strategies for preventing carcinogenesis. Furthermore …
Empagliflozin and doxorubicin synergistically inhibit the survival of triple-negative breast cancer cells via interfering with the mTOR pathway and inhibition of …
SG Eliaa, AA Al-Karmalawy, RM Saleh… - ACS Pharmacology & …, 2020 - ACS Publications
Triple-negative breast cancers (TNBCs) comprise 10–15% of all breast cancers but with
more resistance affinity against chemotherapeutics. Although doxorubicin (DOX) is the …
more resistance affinity against chemotherapeutics. Although doxorubicin (DOX) is the …
Concanavalin-A shows synergistic cytotoxicity with tamoxifen via inducing apoptosis in estrogen receptor-positive breast cancer: In vitro and molecular docking …
Background: Tamoxifen (TAM) is the main treatment of estrogen receptor (ER)-positive
breast cancer, however; its adverse effects and development of resistance hinder its use …
breast cancer, however; its adverse effects and development of resistance hinder its use …
Resveratrol enhances inhibition effects of cisplatin on cell migration and invasion and tumor growth in breast cancer MDA-MB-231 cell models in vivo and in vitro
MD Yang, Y Sun, WJ Zhou, XZ Xie, QM Zhou, YY Lu… - Molecules, 2021 - mdpi.com
Triple-negative breast cancer (TNBC) is a refractory type of breast cancer that does not yet
have clinically effective drugs. The aim of this study is to investigate the synergistic effects …
have clinically effective drugs. The aim of this study is to investigate the synergistic effects …
Synergistic cytotoxic effects of an extremely low-frequency electromagnetic field with doxorubicin on MCF-7 cell line
S Ramazi, M Salimian, A Allahverdi, S Kianamiri… - Scientific Reports, 2023 - nature.com
Breast cancer is one of the leading causes of cancer deaths in women worldwide. Magnetic
fields have shown anti-tumor effects in vitro and in vivo as a non-invasive therapy method …
fields have shown anti-tumor effects in vitro and in vivo as a non-invasive therapy method …
Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms
RG de Oliveira Júnior, AFC Adrielly… - Fitoterapia, 2018 - Elsevier
Purpose Tumor cells are spontaneously or adaptively resistant to chemotherapeutic drugs,
eventually leading to the selection of multiresistant cells responsible for tumor growth and …
eventually leading to the selection of multiresistant cells responsible for tumor growth and …
Harnessing the nutriceutics in early-stage breast cancer: mechanisms, combinational therapy, and drug delivery
Background Breast cancer (BC) is a significant health challenge, ranking as the second
leading cause of cancer-related death and the primary cause of mortality among women …
leading cause of cancer-related death and the primary cause of mortality among women …
Cardiovascular protective effects and clinical applications of resveratrol
S Cho, K Namkoong, M Shin, J Park, E Yang… - Journal of Medicinal …, 2017 - liebertpub.com
Resveratrol is a naturally occurring phenol that is generated by plant species following injury
or attack by bacterial and fungal pathogens. This compound was first described as the …
or attack by bacterial and fungal pathogens. This compound was first described as the …
Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy
B Nayak, GM Balachander, S Manjunath… - Colloids and Surfaces B …, 2019 - Elsevier
Breast cancer cell lines lose the inherent gene expression profiles of their source tumor and
when cultured as monolayers (two-dimensional) are unable to represent patient tumors …
when cultured as monolayers (two-dimensional) are unable to represent patient tumors …